| Q41850512 | A C 21 -Steroidal Glycoside Isolated from the Roots of Cynanchum auriculatum Induces Cell Cycle Arrest and Apoptosis in Human Gastric Cancer SGC-7901 Cells |
| Q38712222 | A Flavone Constituent from Myoporum bontioides Induces M-Phase Cell Cycle Arrest of MCF-7 Breast Cancer Cells. |
| Q48365555 | A Prize for Proliferation |
| Q28296641 | A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis |
| Q37085216 | A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis |
| Q39138529 | A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells |
| Q26822490 | Abscisic acid perception and signaling: structural mechanisms and applications |
| Q36843805 | Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? |
| Q27976463 | Activation of a Plasmodium falciparum cdc2-related kinase by heterologous p25 and cyclin H. Functional characterization of a P. falciparum cyclin homologue |
| Q34285980 | Activation of the Bur1-Bur2 cyclin-dependent kinase complex by Cak1. |
| Q42771035 | All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC. |
| Q35067886 | Alterations at Dispersed Sites Cause Phosphorylation and Activation of SNF1 Protein Kinase during Growth on High Glucose |
| Q27641691 | Alternative binding modes of an inhibitor to two different kinases |
| Q27658342 | An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9 |
| Q52547709 | An essential function of yeast cyclin-dependent kinase Cdc28 maintains chromosome stability. |
| Q45327842 | An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors |
| Q33797218 | An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states. |
| Q28257440 | Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186 |
| Q37356758 | Anti-tumour activity of longikaurin A (LK-A), a novel natural diterpenoid, in nasopharyngeal carcinoma |
| Q40749272 | Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis |
| Q54224728 | Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population. |
| Q35568835 | Aurora A on the mitotic spindle is activated by the way it holds its partner. |
| Q36823669 | Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1). |
| Q37732086 | Autophagy and the Cell Cycle: A Complex Landscape. |
| Q88646106 | Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells |
| Q39304626 | Berberine Inhibits Growth and Induces G1 Arrest and Apoptosis in Human Cholangiocarcinoma QBC939 Cells |
| Q40290758 | Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. |
| Q24563382 | Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor |
| Q34438822 | Bioactive Phytochemical Proanthocyanidins Inhibit Growth of Head and Neck Squamous Cell Carcinoma Cells by Targeting Multiple Signaling Molecules |
| Q27667818 | Briefly Bound to Activate: Transient Binding of a Second Catalytic Magnesium Activates the Structure and Dynamics of CDK2 Kinase for Catalysis |
| Q39635357 | C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cells. |
| Q24555110 | CAK-independent activation of CDK6 by a viral cyclin |
| Q27310333 | CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse |
| Q24302257 | CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms |
| Q34227791 | CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer |
| Q28512218 | CDK6 kinase activity is required for thymocyte development |
| Q36869358 | CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. |
| Q37740906 | CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation |
| Q40214988 | Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest |
| Q39172228 | Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP |
| Q24294546 | Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases |
| Q34979646 | Cdk2-dependent phosphorylation of p21 regulates the role of Cdk2 in cisplatin cytotoxicity |
| Q24299163 | Cdk5: multitasking between physiological and pathological conditions |
| Q38125405 | Cell Cycle Regulation During Neurogenesis in the Embryonic and Adult Brain |
| Q49544319 | Cell Cycle Regulation in Treatment of Breast Cancer. |
| Q36663023 | Cell cycle control as a basis for cancer chemoprevention through dietary agents |
| Q52167690 | Cell cycle control of Schwann cell proliferation: role of cyclin-dependent kinase-2. |
| Q36672102 | Cell cycle control of embryonic stem cells |
| Q38214442 | Cell cycle progression in response to oxygen levels. |
| Q35755163 | Cell cycle regulators at the ocular surface |
| Q24791235 | Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines |
| Q40109655 | Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803. |
| Q37726436 | Cell signaling in protein synthesis ribosome biogenesis and translation initiation and elongation |
| Q41996772 | Cell wall mannoprotein of Candida albicans induces cell cycle alternation and inhibits apoptosis of HaCaT cells via NF-κB signal pathway |
| Q33895611 | Cell-cycle inhibitors: three families united by a common cause |
| Q42834043 | Changes in p21(Cip1) and p27(Kip1) expression are not required for cell cycle entry and progression to S phase in Swiss 3T3 cells |
| Q36880158 | Characterization of Schwann Cells in Self-Assembled Sheets from Thermoresponsive Substrates |
| Q38780162 | Characterization of the cytotoxic activity of [2]rotaxane (TRO-A0001), a novel supramolecular compound, in cancer cells |
| Q53210602 | Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells |
| Q24292699 | Cloning and characterization of a novel human Aurora C splicing variant |
| Q40979505 | Combination of palbociclib and radiotherapy for glioblastoma |
| Q48269673 | Comparative molecular and functional analyses of the tobacco cyclin-dependent kinase inhibitor NtKIS1a and its spliced variant NtKIS1b |
| Q30734049 | Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinoderma mathewsi |
| Q24634569 | Crystal structure of HIV-1 Tat complexed with human P-TEFb |
| Q64229834 | Cyclin C: The Story of a Non-Cycling Cyclin |
| Q34605533 | Cyclin D-dependent kinases, INK4 inhibitors and cancer |
| Q33661435 | Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling. |
| Q42052356 | Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. |
| Q35805077 | Cyclin dependent kinase 11 in RNA transcription and splicing |
| Q56091255 | Cyclin-Dependent Kinases |
| Q39608177 | Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition |
| Q34999448 | Cyclin-dependent kinase homologues of Plasmodium falciparum |
| Q36567048 | Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison |
| Q33900533 | Cyclin-dependent kinases |
| Q33801822 | Cyclin-dependent kinases: inhibition and substrate recognition. |
| Q35056015 | Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development |
| Q35023927 | Cycling at the interface between neurodevelopment and neurodegeneration |
| Q39936380 | Degradation of p21Cip1 through Anaphase-promoting Complex/Cyclosome and Its Activator Cdc20 (APC/CCdc20) Ubiquitin Ligase Complex-mediated Ubiquitylation Is Inhibited by Cyclin-dependent Kinase 2 in Cardiomyocytes |
| Q77527027 | Delayed mammary gland involution in MMTV-AKT1 transgenic mice |
| Q83960761 | Dephosphorylation of Rb (Thr-821) in response to cell stress |
| Q40471536 | Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. |
| Q27027644 | Design principles underpinning the regulatory diversity of protein kinases |
| Q60017679 | Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition |
| Q36421097 | Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity |
| Q37066424 | Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d |
| Q42820724 | Differential regulation of the cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1) by phosphorylation directed by the cyclin encoded by Murine Herpesvirus 68. |
| Q27640893 | Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop |
| Q22254055 | Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities |
| Q95724523 | Effect of Fanbaicao (Herba Potentillae Discoloris) oil on the expression of p21 and CDK4 in HepG2 cells |
| Q53240373 | Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes |
| Q28072336 | Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer |
| Q40026303 | Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells |
| Q55106988 | Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties. |
| Q52717760 | Estrogen receptor beta signaling inhibits PDGF induced human airway smooth muscle proliferation |
| Q40724967 | Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation |
| Q33882449 | Expression of cyclin-dependent kinase inhibitors during corneal wound repair |
| Q53402505 | Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status |
| Q39731350 | Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft |
| Q38887472 | Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells |
| Q30351593 | Flexible nets. The roles of intrinsic disorder in protein interaction networks. |
| Q40346492 | Functional Conservation in the SIAMESE-RELATED Family of Cyclin-Dependent Kinase Inhibitors in Land Plants. |
| Q34489456 | Functional Screen for Secreted Proteins by Monoclonal Antibody Library and Identification of Mac-2 Binding Protein (Mac-2BP) as a Potential Therapeutic Target and Biomarker for Lung Cancer |
| Q39528218 | Functional analysis of the cyclin-dependent kinase inhibitor Pho81 identifies a novel inhibitory domain |
| Q30360720 | Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. |
| Q27935484 | Functional interactions within yeast mediator and evidence of differential subunit modifications |
| Q34368858 | G1 cell-cycle control and cancer |
| Q41871695 | Genetic analysis of the relationship between activation loop phosphorylation and cyclin binding in the activation of the Saccharomyces cerevisiae Cdc28p cyclin-dependent kinase. |
| Q28584893 | Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number |
| Q46688122 | Genome-wide annotation and expression profiling of cell cycle regulatory genes in Chlamydomonas reinhardtii. |
| Q34384695 | Grape Proanthocyanidin Inhibit Pancreatic Cancer Cell Growth In Vitro and In Vivo through Induction of Apoptosis and by Targeting the PI3K/Akt Pathway |
| Q34075693 | Grape Proanthocyanidins Induce Apoptosis by Loss of Mitochondrial Membrane Potential of Human Non-Small Cell Lung Cancer Cells In Vitro and In Vivo |
| Q40145242 | Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki-Cdk-cyclin cascade, and caspase-3 activation via loss of mitochondrial membrane potential |
| Q34052473 | Green Tea Compound in Chemoprevention of Cervical Cancer |
| Q28295783 | Histone Chaperone Jun Dimerization Protein 2 (JDP2): Role in Cellular Senescence and Aging |
| Q34313286 | Histone acetyltransferases: Rising ancient counterparts to protein kinases |
| Q45259068 | Homology model of the CDK1/cyclin B complex. |
| Q36356308 | Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor |
| Q39476105 | Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells |
| Q92962230 | Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine |
| Q38028535 | Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors |
| Q47908483 | Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis. |
| Q54765380 | Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. |
| Q33961317 | INK4d-deficient mice are fertile despite testicular atrophy |
| Q28247078 | Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat |
| Q24292411 | Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor |
| Q53632167 | Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d). |
| Q37124343 | Identification of cell cycle-arrested quiescent osteoclast precursors in vivo |
| Q41457054 | Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent |
| Q74734309 | Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography |
| Q21092150 | Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays |
| Q38088782 | In silicothree-dimensional pharmacophores for aiding the discovery of the Pfmrk (Plasmodium cyclin-dependent protein kinases) specific inhibitors for the therapeutic treatment of malaria |
| Q38842680 | In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression. |
| Q41912454 | Induced mitogenic activity in AML-12 mouse hepatocytes exposed to low-dose ultra-wideband electromagnetic radiation |
| Q39571953 | Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf |
| Q39205003 | Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction. |
| Q47894361 | Influence of Human p16INK4 and p21CIP1 on the in Vitro Activity of Recombinant Plasmodium falciparum Cyclin-Dependent Protein Kinases |
| Q45049610 | Inhibition of HIV-1 virus replication using small soluble Tat peptides |
| Q46603127 | Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells |
| Q36548059 | Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo |
| Q27632159 | Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate |
| Q31098941 | Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity |
| Q42153635 | Ink4‐Arf locus in cancer and aging |
| Q35722786 | Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2 |
| Q28484181 | Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen |
| Q40926668 | Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. |
| Q34594105 | Intrinsic disorder in scaffold proteins: getting more from less |
| Q29614784 | Intrinsically unstructured proteins |
| Q35185629 | Involvement of the INK4a/Arf gene locus in senescence |
| Q39120994 | Isoalantolactone, a sesquiterpene lactone, induces apoptosis in SGC-7901 cells via mitochondrial and phosphatidylinositol 3-kinase/Akt signaling pathways. |
| Q37825439 | Jun dimerization protein 2 controls senescence and differentiation via regulating histone modification |
| Q38190927 | Kinases and pseudokinases: lessons from RAF. |
| Q31456489 | Kinetic basis for activation of CDK2/cyclin A by phosphorylation |
| Q43963596 | Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk. |
| Q44462784 | L63, the Drosophila PFTAIRE, interacts with two novel proteins unrelated to cyclins |
| Q34820689 | Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest |
| Q58992689 | Linear and Nonlinear QSAR Study of N2 and O6 Substituted Guanine Derivatives as Cyclin-Dependent Kinase 2 Inhibitors |
| Q45125293 | Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4. |
| Q89752581 | Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma |
| Q50116500 | Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation. |
| Q39647656 | Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis |
| Q38648606 | MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. |
| Q36645493 | Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways |
| Q38212042 | Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. |
| Q30157355 | Mapping the conformational transition in Src activation by cumulating the information from multiple molecular dynamics trajectories |
| Q27313253 | Mechanism of p27 Unfolding for CDK2 Reactivation. |
| Q21284811 | Melanoma: from melanocyte to genetic alterations and clinical options |
| Q35954892 | Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation |
| Q37279001 | Molecular alterations associated with bladder cancer initiation and progression |
| Q36631844 | Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate |
| Q28533443 | Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design |
| Q28217310 | Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein |
| Q54403056 | Molecular mechanisms of activation in CDK2. |
| Q44298079 | Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells |
| Q42567372 | Morphogenesis signaling components influence cell cycle regulation by cyclin dependent kinase |
| Q44492139 | Mutations in the yeast cyclin-dependent kinase Cdc28 reveal a role in the spindle assembly checkpoint |
| Q28574908 | NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis |
| Q34612458 | Net Expression Inhibits the Growth of Pancreatic Ductal Adenocarcinoma Cell PL45 In Vitro and In Vivo |
| Q24619151 | New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer |
| Q36733083 | Noncatalytic requirement for cyclin A-cdk2 in p27 turnover |
| Q61730531 | Novel functions of plant cyclin-dependent kinase inhibitors, ICK1/KRP1, can act non-cell-autonomously and inhibit entry into mitosis |
| Q42053806 | Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence |
| Q40436456 | Novel role for cyclin-dependent kinase 2 in neuregulin-induced acetylcholine receptor epsilon subunit expression in differentiated myotubes |
| Q33855990 | Novel splice variants of cyclin E with altered substrate specificity |
| Q33735526 | Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition |
| Q38066194 | On the molecular mechanisms of mitotic kinase activation |
| Q35171578 | Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex |
| Q35022751 | P16 and p53 play distinct roles in different subtypes of breast cancer |
| Q48127576 | P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. |
| Q53336689 | PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra |
| Q30613304 | Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. |
| Q44105387 | Peptide inhibitors of CDK2-cyclin A that target the cyclin recruitment-site: structural variants of the C-terminal Phe. |
| Q33635376 | Perspectives in cell cycle regulation: lessons from an anoxic vertebrate |
| Q42112998 | Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4+ T cells and inhibits HIV-1 gene expression |
| Q33373237 | Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop |
| Q46675052 | Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. |
| Q39984081 | Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. |
| Q24537588 | Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation |
| Q40627267 | Phosphorylations of Cyclin-dependent Kinase 2 Revisited Using Two-dimensional Gel Electrophoresis |
| Q37388745 | Polydatin inhibits growth of lung cancer cells by inducing apoptosis and causing cell cycle arrest |
| Q35184499 | Polyphenols from green tea inhibit the growth of melanoma cells through inhibition of class I histone deacetylases and induction of DNA damage |
| Q34668264 | Polyphony: superposition independent methods for ensemble-based drug discovery |
| Q53347678 | Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo |
| Q38538589 | Potential Clinical Uses of CDK Inhibitors: Lessons from Synthetic Lethality Screens |
| Q37527729 | Potential roles of longan flower and seed extracts for anti-cancer |
| Q57789346 | PreSMo Target-Binding Signatures in Intrinsically Disordered Proteins |
| Q35901320 | Prediction of cyclin-dependent kinase phosphorylation substrates |
| Q34978734 | Protein kinase CK2: structure, regulation and role in cellular decisions of life and death |
| Q48618784 | Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors |
| Q40392432 | Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression |
| Q38803278 | Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity |
| Q29540749 | RNA Polymerase II C-Terminal Domain: Tethering Transcription to Transcript and Template |
| Q33905060 | RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function |
| Q34271784 | Rapamycin-resistant proliferation of CD8+ T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity |
| Q39114322 | Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. |
| Q28246814 | Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors" |
| Q47649029 | Regulation by phosphorylation of Pho81p, a cyclin-dependent kinase inhibitor in Saccharomyces cerevisiae |
| Q35147982 | Regulation of CDK4 |
| Q92106577 | Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective |
| Q34076834 | Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle |
| Q35763134 | Regulation of a Myb Transcription Factor by Cyclin-dependent Kinase 2 in Giardia lamblia |
| Q53058216 | Regulation of cell cycle components during exposure to anoxia or dehydration stress in the wood frog, Rana sylvatica |
| Q36572080 | Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. |
| Q35942243 | Rhus coriaria induces senescence and autophagic cell death in breast cancer cells through a mechanism involving p38 and ERK1/2 activation |
| Q38035360 | Role of D-type cyclins in heart development and disease. |
| Q27641651 | Role of flanking sequences and phosphorylation in the recognition of the simian-virus-40 large T-antigen nuclear localization sequences by importin-α |
| Q35745139 | Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice |
| Q89903809 | SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability |
| Q43548171 | Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. |
| Q37766226 | Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review |
| Q24298627 | Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells |
| Q38977408 | Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer. |
| Q34627739 | Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators |
| Q38961268 | Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis |
| Q34538852 | Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells |
| Q35008941 | Sporadic colorectal cancer development shows rejuvenescence regarding epithelial proliferation and apoptosis |
| Q38126722 | Start and the restriction point |
| Q47070620 | Stem cell division is regulated by the microRNA pathway |
| Q34465974 | Structural Basis for Control by Phosphorylation |
| Q30905499 | Structural basis and functions of abscisic acid receptors PYLs. |
| Q27676137 | Structural basis for basal activity and autoactivation of abscisic acid (ABA) signaling SnRK2 kinases |
| Q24298490 | Structural basis of Aurora-A activation by TPX2 at the mitotic spindle |
| Q24597269 | Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors |
| Q34245022 | Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state |
| Q38270181 | Structural characterization of the N-terminal autoregulatory sequence of phenylalanine hydroxylase |
| Q58762403 | Structural insights into the functional diversity of the CDK-cyclin family |
| Q34792851 | Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. |
| Q27652822 | Structure and Substrate Recruitment of the Human Spindle Checkpoint Kinase Bub1 |
| Q27647591 | Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb |
| Q27649148 | Structure of the Pho85-Pho80 CDK-Cyclin Complex of the Phosphate-Responsive Signal Transduction Pathway |
| Q34792862 | Structure-based design of cyclin-dependent kinase inhibitors |
| Q27639756 | Structure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activity |
| Q27677859 | Structure–kinetic relationship study of CDK8/CycC specific compounds |
| Q39167911 | Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest |
| Q33211084 | Synthesis and biological evaluation of thienopyrrolizines, a new family of CDK/GSK-3 inhibitors. |
| Q40559550 | TBP-associated factor 1 overexpression induces tolerance to Doxorubicin in confluent H9c2 cells by an increase in cdk2 activity and cyclin E expression |
| Q28142605 | TGFbeta signaling in growth control, cancer, and heritable disorders |
| Q26796499 | Targeting CDK6 in cancer: State of the art and new insights |
| Q38730812 | Targeting Cyclin-Dependent Kinases in Ovarian Cancer |
| Q34728354 | Targeting the cell cycle for cancer therapy |
| Q33599051 | Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin |
| Q36189481 | The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes. |
| Q34763495 | The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy |
| Q42797018 | The Drosophila mitotic inhibitor Frühstart specifically binds to the hydrophobic patch of cyclins. |
| Q57812379 | The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma |
| Q24810794 | The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix |
| Q28145080 | The INK4 family of cell cycle inhibitors in cancer |
| Q34283464 | The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth |
| Q73693980 | The N-terminal helix of Xenopus cyclins A and B contributes to binding specificity of the cyclin-CDK complex |
| Q34804764 | The RB and p53 pathways in cancer |
| Q24655982 | The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation |
| Q24318515 | The Structure of CDK8/CycC Implicates Specificity in the CDK/Cyclin Family and Reveals Interaction with a Deep Pocket Binder |
| Q35164326 | The biochemistry of mitosis |
| Q29617749 | The cellular geography of aurora kinases |
| Q40212919 | The cyclin dependent kinase subunit Cks1 is required for infection-associated development of the rice blast fungus Magnaporthe oryzae |
| Q27635427 | The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism |
| Q34460347 | The history and future of targeting cyclin-dependent kinases in cancer therapy |
| Q30380115 | The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding |
| Q40492615 | The proliferation inhibitory proteins p27(Kip1) and retinoblastoma are involved in the control of equine lymphocyte proliferation. |
| Q34268736 | The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention |
| Q34088323 | The role and regulation of D-type cyclins in the plant cell cycle |
| Q27681770 | The structures of the kinase domain and UBA domain of MPK38 suggest the activation mechanism for kinase activity |
| Q40067676 | Theaflavins induce G2/M arrest by modulating expression of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma PC-3 cells |
| Q27027457 | Therapeutic targeting of replicative immortality |
| Q85434063 | Thymosin β4 reduces senescence of endothelial progenitor cells via the PI3K/Akt/eNOS signal transduction pathway |
| Q33957955 | To cycle or not to cycle: a critical decision in cancer. |
| Q46523783 | Topochemical models for prediction of cyclin-dependent kinase 2 inhibitory activity of indole-2-ones |
| Q36915763 | Transcriptional repression of p27 is essential for murine embryonic development |
| Q54594584 | Treatment with a cyclin‐dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis |
| Q33727415 | Two maize Kip-related proteins differentially interact with, inhibit and are phosphorylated by cyclin D-cyclin-dependent kinase complexes |
| Q39363654 | Unbalanced Growth, Senescence and Aging. |
| Q33840447 | Viral-encoded cyclins |
| Q33922977 | When protein folding is simplified to protein coiling: the continuum of solenoid protein structures |
| Q34078091 | Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. |
| Q34137912 | p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells |
| Q28910366 | p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding |
| Q42277847 | p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. |
| Q30847612 | p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol |
| Q38272154 | pH‐induced folding of an apoptotic coiled coil |
| Q34985707 | β-Catenin-related protein WRM-1 is a multifunctional regulatory subunit of the LIT-1 MAPK complex |